Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.

Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.
复制标题

DOI:
10.1016/j.virol.2006.12.011
复制
发表时间:
2007-05-25
期刊:
影响因子:
3.7
通讯作者:
Uberla K
Uberla K
中科院分区:
医学3区
文献类型:
--
作者:
Kuate S;Cinatl J;Doerr HW;Uberla K

文献摘要

参考文献

被引文献

相似文献

感染SARS冠状病毒(SARS-CoV)会导致一种致死率很高的非典型肺部疾病。尽管最初的SARS疫情得到了控制,但仍有零星的疾病暴发,这表明持续需要针对这种病毒的疫苗。因此,我们探索了含有SARS-CoV尖峰S蛋白的外体疫苗。将S蛋白的跨膜区和胞浆区替换为VSv-G,获得了含有S的外切体。在小鼠身上测试了含有S的外切体的免疫原性和效力,并与表达S蛋白的腺病毒载体疫苗进行了比较。S外切体和腺病毒载体疫苗均可诱导中和抗体滴度。用SARS-S胞外体疫苗免疫和腺病毒载体加强免疫后,中和抗体效价超过1例SARS患者恢复期血清中和抗体滴度。这两种方法在表达SARS-S的肿瘤挑战模型中都是有效的,因此值得进一步研究。
Infection with the SARS-associated coronavirus (SARS-CoV) induces an atypical pulmonary disease with a high lethality rate. Although the initial SARS epidemic was contained, sporadic outbreaks of the disease still occur, suggesting a continuous need for a vaccine against this virus. We therefore explored exosome-based vaccines containing the spike S proteins of SARS-CoV. S-containing exosomes were obtained by replacing the transmembrane and cytoplasmic domains of the S protein by those of VSV-G. The immunogenicity and efficacy of the S-containing exosomes were tested in mice and compared to an adenoviral vector vaccine expressing the S protein. Both, S-containing exosomes and the adenoviral vector vaccine induced neutralizing antibody titers. After priming with the SARS-S exosomal vaccine and boosting with the adenoviral vector the neutralizing antibody titers exceeded those observed in the convalescent serum of a SARS patient. Both approaches were effective in a SARS-S-expressing tumor challenge model and thus warrant further investigation.
DOI: 10.1016/s1471-4914(03)00133-3
发表时间: 2003-08
影响因子: 13.6
作者:
Drosten C;Preiser W;Günther S;Schmitz H;Doerr HW
通讯作者: Doerr HW
DOI: 10.1016/j.vaccine.2005.08.101
发表时间: 2006-02-13
期刊: VACCINE
影响因子: 5.5
作者:
Bangari, DS;Mittal, SK
通讯作者: Mittal, SK
DOI: 10.1016/s0168-1656(02)00023-8
发表时间: 2002-05-23
影响因子: 4.1
作者:
Chapple, SDJ;Jones, IM
通讯作者: Jones, IM
DOI: 10.1016/s0264-410x(02)00384-5
发表时间: 2002-12-19
期刊: VACCINE
影响因子: 5.5
作者:
André, F;Scharz, NEC;Zitvogel, L
通讯作者: Zitvogel, L
DOI: 10.1128/mcb.7.1.379
发表时间: 1987-01-01
影响因子: 5.3
作者:
DUBRIDGE, RB;TANG, P;CALOS, MP
通讯作者: CALOS, MP